Sodium Oxybate Versus Midazolam for Comfort Sedation
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The study aims at deepen the proof level of sodium oxybate use for comfort sedation at the
end of life in a palliative care unit by comparing it to midazolam in a prospective
randomized study with blinded efficacy evaluation. The study will be carried out for a period
of 24 months with a recruitment objective of 22 patients with refractory suffering and with a
short-term prognosis.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer